General Information of Drug (ID: DM0O4A2)

Drug Name
ETHYL (1E)-2-PHENYL-N-(SULFOOXY)ETHANIMIDOTHIOATE Drug Info
Synonyms
ETHYL (1E)-2-PHENYL-N-(SULFOOXY)ETHANIMIDOTHIOATE; S-BENZYL PHENYLACETOTHIOHYDROXIMATE-O-SULFATE; DB04779; ethyl (1Z)-2-phenyl-N-(sulfooxy)ethanimidothioate; [(Z)-[1-(ethylsulfanyl)-2-phenylethylidene]amino]oxysulfonic acid
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
9600421
TTD Drug ID
DM0O4A2

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Alpha-D-Mannose DMF5DLW Discovery agent N.A. Investigative [2]
Fucose DMAHMSV N. A. N. A. Investigative [2]
Nojirimycine Tetrazole DMYZRTB Discovery agent N.A. Investigative [1]
2,5-dideoxy-2,5-imino-D-altritol DMI1O54 Discovery agent N.A. Investigative [3]
Gluconolactone DMO071E Discovery agent N.A. Investigative [1]
Hyacinthacine B3 DMJ9KNU Discovery agent N.A. Investigative [4]
D-Gluconhydroximo-1,5-Lactam DM527XP Discovery agent N.A. Investigative [1]
2,5-dideoxy-2,5-imino-dl-glycero-D-manno-heptitol DMKP7O0 Discovery agent N.A. Investigative [5]
2-Deoxy-2fluoro-Glucose DMMC8IG Discovery agent N.A. Investigative [2]
⏷ Show the Full List of 9 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Lactase-phlorizin hydrolase (LCT) TTA0OSE LPH_HUMAN Inhibitor [1]

References

1 The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
2 How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
3 2,5-Dideoxy-2,5-imino-d-altritol as a new class of pharmacological chaperone for Fabry disease. Bioorg Med Chem. 2010 Jun 1;18(11):3790-4.
4 New polyhydroxylated pyrrolidine, piperidine, and pyrrolizidine alkaloids from Scilla sibirica. J Nat Prod. 2002 Dec;65(12):1875-81.
5 Nitrogen-containing furanose and pyranose analogues from Hyacinthus orientalis. J Nat Prod. 1998 May;61(5):625-8.